This is a routine governance filing with no immediate trading catalyst. Monitor the EGM on October 2 for any unexpected proposals, but the sole agenda item (board election) is non-controversial. The pipeline updates are backward-looking and do not change the near-term outlook. No action required.
Price Chart
Executive Summary
AC Immune SA filed a 6-K announcing an Extraordinary General Meeting (EGM) on October 2, 2026, to elect Tom Graney to the Board of Directors and the Audit and Finance Committee, replacing Carl June who is stepping down. This is a routine governance filing involving a board member change with no material financial impact. The filing also recaps recent pipeline progress (FDA Fast Track for ACI-7104, Phase 1 data for ACI-19764, ongoing ACI-24 trial) but these are descriptive updates, not new catalysts.
Key Facts
- EGM scheduled for October 2, 2026, to elect Tom Graney as a Board member.
- Tom Graney is a former CFO of Vertex Pharmaceuticals, Ironwood Pharmaceuticals, and Generation Bio, with over 25 years of biopharma experience.
- Carl June is stepping down from the Board and Audit and Finance Committee, effective at the EGM.
- The filing recaps recent pipeline updates: FDA Fast Track for ACI-7104 (Parkinson's), Phase 1 results for ACI-19764 (NLRP3 inhibitor), and ongoing ACI-24 trial with Takeda.
- No financial figures, guidance, or material agreements were disclosed in this filing.
Financial Impact
No financial impact. Board member change is routine governance.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (ACIU) — Batch item 1 | 0000950103-26-013536 |
| Document: dp252870_ex9901.htm | 0000950103-26-013536 |
| Document: dp252870_ex9902.htm | 0000950103-26-013536 |
| Document: dp252870_ex9903.htm | 0000950103-26-013536 |
| Document: 0000950103-26-013536-index-headers.html | 0000950103-26-013536 |
| Document: 0000950103-26-013536-index.html | 0000950103-26-013536 |
| Document: 0000950103-26-013536.txt | 0000950103-26-013536 |
| 6-K Filing (ACIU) — Batch item 8 | 0000950103-26-013536 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | 3/A | $2.45 $2.40 | ▼ −2.04% | ▼ −2.03% | $2.08 (−15.10%) |
Oct 9, 2026 18d ago | 3 | $2.50 $2.45 | ▼ −2.00% | ▼ −1.94% | $2.08 (−16.80%) |
Oct 2, 2026 25d ago | 6-K | $2.73 $2.71 | ▼ −0.55% | ▼ −1.22% | $2.08 (−23.67%) |
Sep 23, 2026 4w ago | 6-K | $2.83 $2.66 | ▼ −6.01% | ▼ −5.92% | $2.08 (−26.50%) |
Sep 3, 2026 7w ago | 6-K | $2.93 $2.86 | ▼ −2.39% | ▼ −2.00% | $2.08 (−29.01%) |
Aug 20, 2026 9w ago | 6-K | $2.64 $2.90 | ▲ +9.85% | ▲ +9.44% | $2.08 (−21.21%) |
Aug 20, 2026 9w ago | Press Release | $2.64 $2.90 | ▲ +9.85% | ▲ +9.44% | $2.08 (−21.21%) |
Aug 11, 2026 11w ago | 6-K | $2.54 $2.62 | ▲ +3.15% | ▲ +2.90% | $2.08 (−18.11%) |
Aug 11, 2026 11w ago | Press Release | $2.54 $2.62 | ▲ +3.15% | ▲ +2.90% | $2.08 (−18.11%) |
Aug 5, 2026 11w ago | 6-K | $2.29 $2.32 | ▲ +1.31% | ▲ +1.47% | $2.08 (−9.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers